Recent Pharmaceuticals Acquisitions in Nevada
Acquisition Volume in Pharmaceuticals in Nevada by Year
Last 5 years
Actual
Full-year estimate
-
January 2, 2024
- Buyer
- Oragenics, Inc.
- Target
- Odyssey Health, Inc. (neurological assets)
- Seller
- Odyssey Health, Inc.
- Industry
- Pharmaceuticals
- Location
- Nevada, United States
- Type
- Divestiture
Oragenics, Inc. completed the acquisition of Odyssey Health, Inc.'s neurological drug therapy assets, including ONP-002, ONP-001 rights, a proprietary intranasal delivery device and related formulations. Odyssey retained its remaining assets and operations; Michael Redmond (former Odyssey CEO) was named President of Oragenics to oversee integration and advancement of the neurology pipeline as Oragenics prepares for Phase 2 studies of ONP-002.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.